0

Multiple Sclerosis Collection
 1-5 of 5 Articles
ACP Journal Club |  18 March 2014
Review: In relapsing–remitting multiple sclerosis, disease-modifying agents reduce annual relapse rates
Brian G. Weinshenker, MD, FRCP(C)
Ann Intern Med. 2014;160(6):JC5. doi:10.7326/0003-4819-160-6-201403180-02005
ACP Journal Club |  18 May 2010
Oral fingolimod was more effective than intramuscular interferon for relapsing–remitting multiple sclerosis
James Hughes, MD
Ann Intern Med. 2010;152(10):JC5-6. doi:10.7326/0003-4819-152-10-201005180-02006
ACP Journal Club |  18 May 2010
Oral fingolimod was more effective than placebo for relapsing–remitting multiple sclerosis
James Hughes, MD
Ann Intern Med. 2010;152(10):JC5-7. doi:10.7326/0003-4819-152-10-201005180-02007
ACP Journal Club |  18 May 2010
Oral cladribine was more effective than placebo for relapsing–remitting multiple sclerosis
James Hughes, MD
Ann Intern Med. 2010;152(10):JC5-8. doi:10.7326/0003-4819-152-10-201005180-02008
ACP Journal Club |  19 January 2010
Glatiramer acetate delayed conversion to multiple sclerosis in patients with clinically isolated syndrome
J.E. Rick Paulseth, MD
Ann Intern Med. 2010;152(2):JC1-10. doi:10.7326/0003-4819-152-2-201001190-02010
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)